We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+4.01%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$21.4B
AUM Growth
+$1.27B
(+6.3%)
Cap. Flow
+$730M
Cap. Flow
% of AUM
3.41%
Top 10 Holdings %
Top 10 Hldgs %
26.79%
Holding
881
New
137
Increased
443
Reduced
202
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AngloGold Ashanti
AU
|
+$259M |
| 2 |
Vale
VALE
|
+$83M |
| 3 |
WPX
WPX Energy, Inc.
WPX
|
+$44.4M |
| 4 |
Gold Fields
GFI
|
+$39.7M |
| 5 |
Royal Gold
RGLD
|
+$35.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$109M |
| 2 |
Newmont
NEM
|
+$96M |
| 3 |
B
Barrick Mining
B
|
+$77.1M |
| 4 |
Franco-Nevada
FNV
|
+$63.2M |
| 5 |
GG
Goldcorp Inc
GG
|
+$58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 50.75% |
| 2 | Energy | 16.94% |
| 3 | Healthcare | 6.45% |
| 4 | Technology | 5.96% |
| 5 | Consumer Staples | 2.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Cencora
COR
$60.3B
| $47.3M | 0.22% |
554,699
+14,603
| +3% | +$1.28M |
|
|
MDR
102
DELISTED
McDermott International
MDR
| $47.2M | 0.22% |
2,401,720
+802,170
| +50% | +$16.3M |
|
103
McKesson
MCK
$98.5B
| $46.5M | 0.22% |
348,738
+17,082
| +5% | +$2.5M |
|
104
Huazhu Hotels Group
HTHT
$12.4B
| $43.6M | 0.2% |
1,038,268
-347,720
| -25% | -$13.9M |
|
105
CVS Health
CVS
$137B
| $43.5M | 0.2% |
675,754
+111,208
| +20% | +$7.33M |
|
106
Salesforce
CRM
$134B
| $42.6M | 0.2% |
312,588
+2,288
| +0.7% | +$292K |
|
107
PepsiCo
PEP
$186B
| $41.6M | 0.19% |
381,665
+215,782
| +130% | +$22.3M |
|
108
Medtronic
MDT
$107B
| $41.5M | 0.19% |
485,085
+51,332
| +12% | +$4.29M |
|
109
Walt Disney
DIS
$165B
| $41.4M | 0.19% |
395,076
+43,187
| +12% | +$4.42M |
|
|
MXIM
110
DELISTED
Maxim Integrated Products
MXIM
| $40.9M | 0.19% |
696,612
+9,596
| +1% | +$559K |
|
111
Dominion Energy
D
$62.5B
| $40.7M | 0.19% |
597,335
+318,027
| +114% | +$20.7M |
|
112
Procter & Gamble
PG
$343B
| $40.7M | 0.19% |
521,279
+289,394
| +125% | +$21.8M |
|
113
Skyworks Solutions
SWKS
$9.06B
| $40.4M | 0.19% |
418,169
-15,568
| -4% | -$1.51M |
|
114
Louisiana-Pacific
LPX
$5.2B
| $40.4M | 0.19% |
1,483,442
+50,410
| +4% | +$1.45M |
|
115
Mondelez International
MDLZ
$77.7B
| $40.2M | 0.19% |
980,986
+134,001
| +16% | +$5.39M |
|
116
Wells Fargo
WFC
$261B
| $40.2M | 0.19% |
724,610
+97,490
| +16% | +$5.22M |
|
117
Campbell Soup
CPB
$6.51B
| $39.4M | 0.18% |
973,057
+550,110
| +130% | +$21.4M |
|
|
SA
118
Seabridge Gold
SA
$2.8B
| $39.4M | 0.18% |
3,530,693
+183,600
| +5% | +$1.98M |
|
119
GE Aerospace
GE
$367B
| $39.2M | 0.18% |
601,541
+162,061
| +37% | +$10.8M |
|
120
Idexx Laboratories
IDXX
$42.9B
| $39.2M | 0.18% |
179,704
+6,227
| +4% | +$1.28M |
|
121
Comcast
CMCSA
$79.1B
| $38.6M | 0.18% |
1,175,051
+670,605
| +133% | +$21.9M |
|
|
XLNX
122
DELISTED
Xilinx Inc
XLNX
| $38M | 0.18% |
582,029
+44,497
| +8% | +$3.03M |
|
123
Ares Capital
ARCC
$13.5B
| $37.7M | 0.18% |
2,290,979
+65,013
| +3% | +$1.07M |
|
|
ESRX
124
DELISTED
Express Scripts Holding Company
ESRX
| $36.8M | 0.17% |
476,184
-53,620
| -10% | -$4.02M |
|
125
Bristol-Myers Squibb
BMY
$127B
| $36.7M | 0.17% |
663,800
+201,430
| +44% | +$10.9M |
|
Similar funds
DAM
VanEck Associates's Q2 2018 Portfolio in Review
As of Q2 2018, VanEck Associates held 881 positions worth $21.4B, up 6.3% from $20.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
VanEck Associates deployed $730M of net new capital in Q2 2018, opening 137 new positions and adding to 443 existing holdings. Its largest new stake was Colgate-Palmolive: 345,613 shares worth $22.4M.
By sector, the portfolio is most concentrated in Materials at 51% of assets, down from 52% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Newmont, an estimated $96M trimmed.
- VanEck Associates's largest Q2 2018 buy was Colgate-Palmolive: 345,613 shares worth $22.4M.
- VanEck Associates added most to AngloGold Ashanti in Q2 2018, an estimated $259M increase.
- VanEck Associates's biggest Q2 2018 reduction was Newmont, cutting an estimated $96M.
- VanEck Associates fully exited Monsanto Co in Q2 2018, selling an estimated $109M.
- VanEck Associates's ten largest holdings make up 27% of its $21.4B portfolio in Q2 2018.
- VanEck Associates opened 137 new positions and closed 30 in Q2 2018.
- VanEck Associates's portfolio value rose 6.3% quarter-over-quarter to $21.4B.
Based on VanEck Associates's 13F filing for Q2 2018, filed 13 Aug 2018.